SK280130B6 - Komplex zrážacieho faktora ix, spôsob jeho výroby, - Google Patents

Komplex zrážacieho faktora ix, spôsob jeho výroby, Download PDF

Info

Publication number
SK280130B6
SK280130B6 SK211-92A SK21192A SK280130B6 SK 280130 B6 SK280130 B6 SK 280130B6 SK 21192 A SK21192 A SK 21192A SK 280130 B6 SK280130 B6 SK 280130B6
Authority
SK
Slovakia
Prior art keywords
factor
complex
protein
vitamin
aqueous mixture
Prior art date
Application number
SK211-92A
Other languages
English (en)
Slovak (sk)
Inventor
Yendra Linnau
Maria Sazgary
Original Assignee
Immuno Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Aktiengesellschaft filed Critical Immuno Aktiengesellschaft
Publication of SK280130B6 publication Critical patent/SK280130B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)
SK211-92A 1991-01-25 1992-01-24 Komplex zrážacieho faktora ix, spôsob jeho výroby, SK280130B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0016391A AT402261B (de) 1991-01-25 1991-01-25 Komplex enthaltend den gerinnungsfaktor ix

Publications (1)

Publication Number Publication Date
SK280130B6 true SK280130B6 (sk) 1999-08-06

Family

ID=3483232

Family Applications (2)

Application Number Title Priority Date Filing Date
SK1633-98A SK280989B6 (sk) 1991-01-25 1992-01-24 Spôsob výroby farmaceutického preparátu obsahujúceho zrážací faktor ix
SK211-92A SK280130B6 (sk) 1991-01-25 1992-01-24 Komplex zrážacieho faktora ix, spôsob jeho výroby,

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SK1633-98A SK280989B6 (sk) 1991-01-25 1992-01-24 Spôsob výroby farmaceutického preparátu obsahujúceho zrážací faktor ix

Country Status (12)

Country Link
US (2) US5281661A (ja)
EP (1) EP0496725B1 (ja)
JP (2) JP2651307B2 (ja)
AT (2) AT402261B (ja)
CA (1) CA2059979C (ja)
CZ (2) CZ154794A3 (ja)
DE (1) DE59207638D1 (ja)
DK (1) DK0496725T3 (ja)
ES (1) ES2098485T3 (ja)
FI (1) FI100111B (ja)
HU (1) HU212362B (ja)
SK (2) SK280989B6 (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0573605T3 (da) * 1991-03-01 2001-01-02 Rhone Poulenc Rorer Int Fremstilling af faktor IX
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
JP3521256B2 (ja) * 1994-06-30 2004-04-19 デイド、ベーリング、インコーポレイテッド 生物活性の多孔性仕切り部材
US5602037A (en) * 1994-06-30 1997-02-11 Dade International, Inc. Combination reagent holding and test device
US5888826A (en) * 1994-06-30 1999-03-30 Dade Behring Inc. Combination reagent holding and test device
DE19506633A1 (de) * 1995-02-25 1996-08-29 Octapharma Ag Verfahren zur Herstellung von Faktor IX aus biologischen Quellen
US5714583A (en) * 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
US5958716A (en) * 1996-06-06 1999-09-28 Dade Behring Inc. Blood factor assay
CN1284881A (zh) * 1997-11-05 2001-02-21 吉富制药株式会社 肝素辅助因子ⅱ制剂及其制备方法
WO2005033140A1 (ja) * 2003-09-30 2005-04-14 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 高純度血液凝固ｉｘ因子調製物およびその精製方法
JP2008505119A (ja) * 2004-06-30 2008-02-21 ネクター セラピューティクス アラバマ，コーポレイション 高分子−第ｉｘ因子部分の抱合体
BRPI0519626A2 (pt) * 2004-12-23 2009-02-25 Novo Nordisk Healthcare Ag mÉtodos para a reduÇço do teor de um ou mais contaminantes, do teor de proteÍna s em uma composiÇço, do teor de um ou mais contaminantes de proteÍna em um sobrenadante de cultura de cÉlula, do teor de proteÍna s em um sobrenadante de cultura de cÉlula, composiÇço compreendendo uma proteÍna dependente de vitamina k de interesse
EP3708581A3 (en) 2009-05-27 2021-10-20 Takeda Pharmaceutical Company Limited A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
JP5734985B2 (ja) 2009-09-17 2015-06-17 バクスター・ヘルスケヤー・ソシエテ・アノニムＢａｘｔｅｒ Ｈｅａｌｔｈｃａｒｅ ＳＡ ヒアルロニダーゼおよび免疫グロブリンの安定な共製剤およびそれらの使用方法
AR083035A1 (es) 2010-09-17 2013-01-30 Baxter Int ESTABILIZACION DE INMUNOGLOBULINAS MEDIANTE UNA FORMULACION ACUOSA CON HISTIDINA A pH ACIDO DEBIL A NEUTRO, COMPOSICION ACUOSA DE INMUNOGLOBULINA
SG191186A1 (en) 2010-12-15 2013-07-31 Baxter Int Eluate collection using conductivity gradient
CA2864868A1 (en) 2011-02-25 2012-11-15 Wellstat Diagnostics, Llc Assays for detecting enzymatic activity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2543448A1 (fr) * 1983-04-01 1984-10-05 Rhone Poulenc Spec Chim Procede de fractionnement du plasma
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
ATE130620T1 (de) * 1986-01-06 1995-12-15 Blood Systems Inc Therapeutisches blutprodukt, mittel und verfahren zu dessen erzeugung.
JPS63108000A (ja) * 1986-05-15 1988-05-12 Green Cross Corp:The 第８因子の精製方法
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
EP0317376B2 (fr) * 1987-10-23 1996-04-03 Centre Regional De Transfusion Sanguine De Lille Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques
DE3914869C1 (ja) * 1989-05-05 1990-08-09 Biotest Pharma Gmbh, 6072 Dreieich, De

Also Published As

Publication number Publication date
ATA16391A (de) 1996-08-15
DE59207638D1 (de) 1997-01-23
EP0496725A2 (de) 1992-07-29
HU9200225D0 (en) 1992-04-28
HUT63863A (en) 1993-10-28
JP2651307B2 (ja) 1997-09-10
FI920342A0 (fi) 1992-01-24
CZ280725B6 (cs) 1996-04-17
EP0496725B1 (de) 1996-12-11
DK0496725T3 (da) 1997-06-09
SK280989B6 (sk) 2000-10-09
EP0496725A3 (en) 1993-05-05
CA2059979A1 (en) 1992-07-26
ATE146220T1 (de) 1996-12-15
ES2098485T3 (es) 1997-05-01
CZ280297B6 (cs) 1995-12-13
JPH08259449A (ja) 1996-10-08
CS21192A3 (en) 1992-08-12
CA2059979C (en) 2003-04-15
HU212362B (en) 1996-06-28
CZ154794A3 (en) 1996-04-17
AT402261B (de) 1997-03-25
US5409990A (en) 1995-04-25
JPH04295432A (ja) 1992-10-20
FI920342A (fi) 1992-07-26
US5281661A (en) 1994-01-25
FI100111B (fi) 1997-09-30
JP2866047B2 (ja) 1999-03-08

Similar Documents

Publication Publication Date Title
SK280130B6 (sk) Komplex zrážacieho faktora ix, spôsob jeho výroby,
US4687664A (en) Method of inactivating reproducible pathogens
US6005082A (en) Process for purification of factor VIII
IE44507B1 (en) Cationic material capable of reversibly fixing biological macromolecules
CA2491716A1 (en) Processes for the preparation of fibrinogen
FI106468B (fi) Menetelmä virusturvallisen, erittäin puhtaan tekijä VIII:n valmistamiseksi
EP0391974B1 (en) Process for the purification of vitamin k-dependent blood clotting factors
Sakamoto et al. Studies on the interaction between heparin and mouse bone collagenase
NL7905045A (nl) Werkwijze voor de bereiding van zuivere urokinase.
AU747274B2 (en) Improved methods for producing factor VIII proteins
JPH053480B2 (ja)
JPH02113893A (ja) 凝固因子２、７、９およびｘの１または２以上を濃縮する方法
Josić et al. Size-exclusion chromatography of plasma proteins with high molecular masses
JP3043558B2 (ja) ヒト活性化プロテインｃ調製物及びその製法
US5445958A (en) Process for purifying blood clotting factors
EA000222B1 (ru) Способ получения фактора ix из биологических источников и фактор ix, полученный этим способом
JPS6034916A (ja) 第１ｘ因子および他のビタミンｋ依存性タンパク質の高純度精製
JP2926728B2 (ja) 蛋白質含有組成物の製造方法
EP0813597B1 (en) A process for the purification of vitamin k dependent coagulation factors by chromatography
AU627446C (en) Chemical process
JPH0795894A (ja) リポコルチンの精製方法
KIZUKI et al. Porcine pancreatic prokallikrein. II. Purification and some properties of prokallikrein A
JP2003096094A (ja) プロテインｓの精製法および高比活性プロテインｓ調製物
JPH01148185A (ja) 逆相液体クロマトグラフィーによるｔ−ＰＡ精製方法
CZ2000983A3 (cs) Způsob čištění antithrombinu III